Search for: "Sage v. Johnson" Results 1 - 20 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2019, 1:00 pm by Daily Record Staff
Torts — Jury instruction — Contributory negligence In May 2014, Jennifer Ogunde was attacked by a 70-pound female American Bulldog named Sage, causing Ogunde to fall and injure her knee. [read post]
15 May 2012, 11:03 am by Steve
Johnson, of Washington, as a judge of the Twenty-eighth Judicial Circuit for a term of eight years commencing July 1, 2012.to the General District Courts - V. [read post]
13 Apr 2017, 4:26 am by Jon Hyman
When a judicial opinion starts out with a quote such as this, it’s usually not a good sign for the defendant, unless you happen to be the United Auto Workers, the defendant in Phillips v. [read post]
27 Jul 2015, 11:10 am by Law Lady
Ostendorf and making explicit findings on each factor -- Where counsel is involved in conduct to be sanctioned Kozel analysis is required before entering judicial default, and failure to do so is, by itself, basis for remandDOROTHY CHAPPELLE, CALVIN JOHNSON and EVELYN WILLIAMS, Appellants, v. [read post]
13 May 2016, 12:48 pm
Sage, 31 Ohio St.3d 173, 510 N.E.2d 343 (1987), paragraph two of the syllabus.Pursuant to Evid.R. 803(6), business records are an exception to the hearsay rule. [read post]
23 May 2012, 4:00 pm by John Elwood
Johnson, 11-1053, a state-on-top habeas case out of the Third Circuit; Parker, Warden v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]